Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
British Journal of Cancer
|
March 24, 2020
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
Daniel Eiger, Noam F Pondé, Dominique Agbor-Tarh, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 19, 2010
Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus
Harini A Chakkera, William C Knowler, Yugandhara Devarapalli, et al.
JNCI Cancer Spectrum
|
March 28, 2025
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review
Amanda L King, Tamara Vasilj, Diane Cooper, et al.
Blood Advances
|
November 20, 2020
Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin
Bridget K Marcellino, Noushin Farnoud, Bruno Cassinat, et al.
Archives of Dermatological Research
|
February 14, 2025
Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus
Nan Zhang, Alyssa L Stockard, Zachary Leibovit-Reiben, et al.
JCO Oncology Practice
|
May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care
Surbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
Cancer Research Communications
|
February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 22, 2023
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
British Journal of Cancer
|
March 24, 2020
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
Daniel Eiger, Noam F Pondé, Dominique Agbor-Tarh, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 19, 2010
Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus
Harini A Chakkera, William C Knowler, Yugandhara Devarapalli, et al.
JNCI Cancer Spectrum
|
March 28, 2025
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review
Amanda L King, Tamara Vasilj, Diane Cooper, et al.
Blood Advances
|
November 20, 2020
Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin
Bridget K Marcellino, Noushin Farnoud, Bruno Cassinat, et al.
Archives of Dermatological Research
|
February 14, 2025
Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus
Nan Zhang, Alyssa L Stockard, Zachary Leibovit-Reiben, et al.
JCO Oncology Practice
|
May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care
Surbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
Cancer Research Communications
|
February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 22, 2023
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)
Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.
Page
of 5